» Articles » PMID: 39650598

Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge

Abstract

Magnetic resonance (MR)-guided radiation therapy (RT) is enhancing head and neck cancer (HNC) treatment through superior soft tissue contrast and longitudinal imaging capabilities. However, manual tumor segmentation remains a significant challenge, spurring interest in artificial intelligence (AI)-driven automation. To accelerate innovation in this field, we present the Head and Neck Tumor Segmentation for MR-Guided Applications (HNTS-MRG) 2024 Challenge, a satellite event of the 27th International Conference on Medical Image Computing and Computer Assisted Intervention. This challenge addresses the scarcity of large, publicly available AI-ready adaptive RT datasets in HNC and explores the potential of incorporating multi-timepoint data to enhance RT auto-segmentation performance. Participants tackled two HNC segmentation tasks: automatic delineation of primary gross tumor volume (GTVp) and gross metastatic regional lymph nodes (GTVn) on pre-RT (Task 1) and mid-RT (Task 2) T2-weighted scans. The challenge provided 150 HNC cases for training and 50 for testing, hosted on grand-challenge.org using a Docker submission framework. In total, 19 independent teams from across the world qualified by submitting both their algorithms and corresponding papers, resulting in 18 submissions for Task 1 and 15 submissions for Task 2. Evaluation using the mean aggregated Dice Similarity Coefficient showed top-performing AI methods achieved scores of 0.825 in Task 1 and 0.733 in Task 2. These results surpassed clinician interobserver variability benchmarks, marking significant strides in automated tumor segmentation for MR-guided RT applications in HNC.

References
1.
Pollard J, Wen Z, Sadagopan R, Wang J, Ibbott G . The future of image-guided radiotherapy will be MR guided. Br J Radiol. 2017; 90(1073):20160667. PMC: 5605101. DOI: 10.1259/bjr.20160667. View

2.
Burnet N, Thomas S, Burton K, Jefferies S . Defining the tumour and target volumes for radiotherapy. Cancer Imaging. 2008; 4(2):153-61. PMC: 1434601. DOI: 10.1102/1470-7330.2004.0054. View

3.
Isensee F, Jaeger P, Kohl S, Petersen J, Maier-Hein K . nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. 2020; 18(2):203-211. DOI: 10.1038/s41592-020-01008-z. View

4.
Gregoire V, Evans M, Le Q, Bourhis J, Budach V, Chen A . Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG.... Radiother Oncol. 2017; 126(1):3-24. DOI: 10.1016/j.radonc.2017.10.016. View

5.
McDonald B, Dal Bello R, Fuller C, Balermpas P . The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance. Semin Radiat Oncol. 2023; 34(1):69-83. PMC: 11372437. DOI: 10.1016/j.semradonc.2023.10.003. View